Patents by Inventor Hiroyuki Okabe

Hiroyuki Okabe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10453780
    Abstract: An electronic circuit according to this invention includes a printed circuit board and an electronic component that is soldered onto the printed circuit board. The electronic component is a flat package including a die pad exposed to outside and external electrode terminals. A gap is provided between the printed circuit board and the electronic component. The printed circuit board is provided with a hole between the die pad and the external electrode terminals in planar view. The gap is filled with insulating resin at least partially between the die pad and the external electrode terminals. The insulating resin is injected through the hole.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: October 22, 2019
    Assignee: Mitsubishi Electric Corporation
    Inventors: Rei Yoneyama, Nobuya Nishida, Hiroyuki Okabe
  • Publication number: 20190294775
    Abstract: An authentication method for authenticating an electronic ticket stored in a portable information device by an authentication apparatus, including a step of acquiring, by the portable information device, shared information that is sharable with the authentication apparatus when authentication of the electronic ticket is performed, a step of generating, by the portable information device, a bar code based on the acquired shared information and the electronic ticket, a step of displaying the bar code by the portable information device, a step of reading, by the authentication apparatus, the electronic ticket and the shared information from the bar code displayed on the portable information device, and a step of performing, by the authentication apparatus, the authentication of the electronic ticket by making a comparison between contents of the shared information read from the bar code together with the electronic ticket and shared information in the authentication apparatus.
    Type: Application
    Filed: March 19, 2019
    Publication date: September 26, 2019
    Applicant: CASIO COMPUTER CO., LTD.
    Inventor: Hiroyuki OKABE
  • Publication number: 20190259574
    Abstract: Disclosed are a charged particle beam apparatus wherein the charged particle beam apparatus can efficiently performs finish processing of a sample and acquisition of a high-precision SEM image of a processing surface of the sample in a short time, and a sample processing observation method using the same. The charged particle beam apparatus includes: a gallium ion beam column radiating a gallium ion beam toward a sample to form a cross-section of the sample; an electron beam column having a semi-in-lens type objective lens and radiating an electron beam toward the sample; a gas ion beam column radiating a gas ion beam toward the sample to perform finish processing of the cross-section of the sample, wherein the gas ion beam has a beam diameter larger than a maximum diameter of the cross-section of the sample.
    Type: Application
    Filed: February 19, 2019
    Publication date: August 22, 2019
    Inventors: Yo YAMAMOTO, Shota TORIKAWA, Hidekazu SUZUKI, Hiroyuki SUZUKI, Mamoru OKABE, Tatsuya ASAHATA
  • Publication number: 20190148251
    Abstract: This semiconductor device includes: a first insulation resin portion formed on the mounting surface side of a lead frame; a second insulation resin portion formed on the heat dissipation surface side of the lead frame; and a heatsink fixed to the heat dissipation surface of the second insulation resin portion, wherein the second insulation resin portion has a second skirt portion formed at an end of a thin molded portion, the first insulation resin portion has a first skirt portion covering the second skirt portion, and an outer peripheral surface part of the second skirt portion has a first end connected to the lead frame and the first skirt portion, a second end connected to the heatsink, and at least one bent portion formed between the first end and the second end.
    Type: Application
    Filed: June 9, 2017
    Publication date: May 16, 2019
    Applicant: Mitsubishi Electric Corporation
    Inventors: Yuki OKABE, Takanobu KAJIHARA, Junya SUZUKI, Muneaki MUKUDA, Hiroyuki MIYANISHI
  • Patent number: 10116302
    Abstract: A high-side switching element is provided between a main output terminal having an intermediate potential and a high-side terminal. A signal transmission circuit includes a first point, a second point, a signal switching element, and a diode. The intermediate potential is applied to the first point. A referred potential between the low-side potential and the high-side potential is applied to the second point. The signal switching element has a first end connected to the first point and a second end, and is switched in accordance with a conversion signal. The diode is provided between the second point and the second end of the signal switching element and has a direction with which a forward current can flow by a voltage between the first point and the second point in a case where the intermediate potential is the low-side potential.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: October 30, 2018
    Assignee: Mitsubishi Electric Corporation
    Inventors: Haruhiko Murakami, Rei Yoneyama, Masayuki Ando, Hiroyuki Okabe
  • Patent number: 10092589
    Abstract: In order to provide a novel cancer treatment method using a FTD?TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side effects, the present invention provides an anti-tumor agent characterized in that the FTD?TPI combination drug and an anti-tumor platinum complex are administered in combination.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: October 9, 2018
    Assignee: Taiho Pharmaceutical Company Limited
    Inventor: Hiroyuki Okabe
  • Patent number: 9943537
    Abstract: Provided is a novel method for treating a cancer using an FTD/TPI combination drug, which shows remarkably excellent antitumor effect and small adverse effects. An antitumor agent, in which a combination drug containing trifluridine and tipiracil hydrochloride at a molar ratio of 1:0.5 and an anti-VEGF antibody or anti-EGFR antibody are administered in combination.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: April 17, 2018
    Assignee: TAIHO PHARMACEUTICAL CO., LTD.
    Inventor: Hiroyuki Okabe
  • Publication number: 20170216339
    Abstract: In order to provide a novel cancer treatment method using a FTD-TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side effects, the present invention provides an anti-tumor agent characterized in that the FTD-TPI combination drug and an anti-tumor platinum complex are administered in combination.
    Type: Application
    Filed: April 3, 2015
    Publication date: August 3, 2017
    Inventor: Hiroyuki Okabe
  • Publication number: 20170112866
    Abstract: In order to provide a novel cancer treatment method using a FTD•TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side effects, the present invention provides an anti-tumor agent characterized in that the FTD•TPI combination drug and a taxane compound are administered in combination.
    Type: Application
    Filed: April 3, 2015
    Publication date: April 27, 2017
    Inventor: Hiroyuki Okabe
  • Patent number: 9616081
    Abstract: Provided is a novel combination therapy using an FTD/TPI combination drug which exhibits remarkable antitumor effects, and few side effects. An antitumor agent is characterized in that the FTD/TPI combination drug is administered, using a reduced amount of trifluridine, at a dose in the range of 35 to 70 mg/m2/day and CPT-11 is administered at a dose in the range of 45 to 144 mg/m2/day.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: April 11, 2017
    Assignee: TAIHO PHARMACEUTICAL CO., LTD.
    Inventor: Hiroyuki Okabe
  • Patent number: 9616082
    Abstract: Provided is a novel combination therapy using an FTD/TPI combination drug which exhibits remarkable antitumor effects, and few side effects. An antitumor agent is characterized in that one cycle of an administration schedule, in which, in a period of 14 days, the FTD/TPI combination drug is administered on days 1 to 5, and CPT-11 is administered on day 1, is repeated at least once.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: April 11, 2017
    Assignee: TAIHO PHARMACEUTICAL CO., LTD.
    Inventor: Hiroyuki Okabe
  • Patent number: 9613888
    Abstract: A semiconductor device in the preferred embodiment includes: a lead frame comprising a die pad and an electrode terminal; and at least one semiconductor chip bonded to a surface of the die pad, wherein the lead frame excluding a bottom surface thereof and the semiconductor chip are sealed by a sealing resin, and an unevenness is introduced on a bonding interface between the surface of the die pad and the semiconductor chip.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: April 4, 2017
    Assignee: Mitsubishi Electric Corporation
    Inventors: Rei Yoneyama, Hiroyuki Okabe, Nobuya Nishida, Taichi Obara
  • Publication number: 20160193241
    Abstract: Provided is a novel method for treating a cancer using an FTD/TPI combination drug, which shows remarkably excellent antitumor effect and small adverse effects. An antitumor agent, in which a combination drug containing trifluridine and tipiracil hydrochloride at a molar ratio of 1:0.5 and an anti-VEGF antibody or anti-EGFR antibody are administered in combination.
    Type: Application
    Filed: September 5, 2014
    Publication date: July 7, 2016
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventor: Hiroyuki OKABE
  • Patent number: 9371380
    Abstract: This invention provides a method for predicting a therapeutic effect of chemotherapy that uses an antitumor agent comprising ?,?,?-trifluorothymidine and 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil hydrochloride at a molar ratio of 1:0.5 on a colorectal cancer patient, the method comprising: (1) detecting the presence or absence of KRAS gene mutation in a biological sample obtained from the patient; and (2) predicting that the patient is likely to sufficiently respond to the chemotherapy, when KRAS gene mutation is detected in Step (1).
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: June 21, 2016
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Masanobu Ito, Hiroyuki Okabe
  • Patent number: 9357678
    Abstract: A semiconductor module can be attached to a heat sink. The semiconductor module includes a case housing a component of the semiconductor module, and an elastic member having one end engaging with the case and an opposite end in abutting contact with the heat sink. The elastic member forms a gap between the case and the heat sink, and heat conductive grease is appliable to the gap to be interposed between the case and the heat sink.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: May 31, 2016
    Assignee: MITSUBISHI ELECTRIC CORPORATION
    Inventors: Leijie Zhou, Hiroyuki Okabe
  • Publication number: 20160082031
    Abstract: Provided is a novel combination therapy using an FTD/TPI combination drug which exhibits remarkable antitumor effects, and few side effects. An antitumor agent is characterized in that the FTD/TPI combination drug is administered, using a reduced amount of trifluridine, at a dose in the range of 35 to 70 mg/m2/day and CPT-11 is administered at a dose in the range of 45 to 144 mg/m2/day.
    Type: Application
    Filed: March 27, 2014
    Publication date: March 24, 2016
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventor: Hiroyuki OKABE
  • Publication number: 20160045530
    Abstract: Provided is a novel combination therapy using an FTD/TPI combination drug which exhibits remarkable antitumor effects, and few side effects. An antitumor agent is characterized in that one cycle of an administration schedule, in which, in a period of 14 days, the FTD/TPI combination drug is administered on days 1 to 5, and CPT-11 is administered on day 1, is repeated at least once.
    Type: Application
    Filed: March 27, 2014
    Publication date: February 18, 2016
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventor: Hiroyuki OKABE
  • Publication number: 20160049358
    Abstract: An electronic circuit according to this invention includes a printed circuit board and an electronic component that is soldered onto the printed circuit board. The electronic component is a flat package including a die pad exposed to outside and external electrode terminals. A gap is provided between the printed circuit board and the electronic component. The printed circuit board is provided with a hole between the die pad and the external electrode terminals in planar view. The gap is filled with insulating resin at least partially between the die pad and the external electrode terminals. The insulating resin is injected through the hole.
    Type: Application
    Filed: October 30, 2015
    Publication date: February 18, 2016
    Applicant: MITSUBISHI ELECTRIC CORPORATION
    Inventors: Rei YONEYAMA, Nobuya NISHIDA, Hiroyuki OKABE
  • Patent number: 9252087
    Abstract: An electronic circuit according to this invention includes a printed circuit board and an electronic component that is soldered onto the printed circuit board. The electronic component is a flat package including a die pad exposed to outside and external electrode terminals. A gap is provided between the printed circuit board and the electronic component. The printed circuit board is provided with a hole between the die pad and the external electrode terminals in planar view. The gap is filled with insulating resin at least partially between the die pad and the external electrode terminals. The insulating resin is injected through the hole.
    Type: Grant
    Filed: July 25, 2013
    Date of Patent: February 2, 2016
    Assignee: Mitsubishi Electric Corporation
    Inventors: Rei Yoneyama, Nobuya Nishida, Hiroyuki Okabe
  • Patent number: 9125308
    Abstract: A semiconductor device includes a first printed circuit board, a flat cable having electrical wires and a coating film which covers the electrical wires except for both ends, one end of each of the electrical wires is connected to the first printed circuit board, and a second printed circuit board connected to other end of each of the electrical wires. The flat cable is bent in such a manner that the first printed circuit board and the second printed circuit board face each other. A flat surface is formed in a portion of the coating film.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: September 1, 2015
    Assignee: Mitsubishi Electric Corporation
    Inventors: Taichi Obara, Rei Yoneyama, Hiroyuki Okabe